Article
A pharmacogenetic-driven approach for controlled ovarian hyperstimulation by FSH treatment.
Minerva ginecologica - 1 Dec 2014
Colognato R, Aiello R, Dulcetti F, Ruggeri A M, De Toffol S, Marcato L, Irollo A M, Criscuolo C, Gangale M F, Maggi F, Simoni G
Abstract excerpt
AIM: The aim of this study was to develop a pharmacogenetic- (PGx) driven approach for a controlled ovarian hyperstimulation (COH) treatment protocol used for in vitro fertilization procedures. The enrolled patients were genotyped for a single nucleotide polymorphism (SNP) N680S, within the FSHR. METHODS: Seventy-eight women, who had previously received at least two COH cycles without positive fertilization with...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.